In this episode of “The Top Line”, Fierce Pharma interviews Delara Motlagh, head of cell therapy at Catalent and other industry experts. The conversation covers the critical step of cell collection & they also discuss the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and market. https://ow.ly/JfhN50Sz5n5
Catalent Pharma Solutions’ Post
More Relevant Posts
-
In this episode of “The Top Line”, Fierce Pharma interviews Delara Motlagh, head of cell therapy at Catalent and other industry experts. The conversation covers the critical step of cell collection & they also discuss the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and market. https://ow.ly/jgs350Skq7L
-
Talent Acquisition Sourcer at Catalent Pharma Solutions | Biologics, Cell & Gene Therapy
In this episode of “The Top Line”, Fierce Pharma interviews Delara Motlagh, head of cell therapy at Catalent and other industry experts. The conversation covers the critical step of cell collection & they also discuss the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and market. https://ow.ly/jgs350Skq7L
From cell collection to commercial contracting: Advancements in cell & gene therapy manufacturing (Part II)
-
In this episode of “The Top Line”, Fierce Pharma interviews Delara Motlagh, head of cell therapy at Catalent and other industry experts. The conversation covers the critical step of cell collection & they also discuss the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and market. https://ow.ly/jgs350Skq7L
-
-
Talent Acquisition Sourcer, BioModalities, at Catalent Pharma Solutions
In this episode of “The Top Line”, Fierce Pharma interviews Delara Motlagh, head of cell therapy at Catalent and other industry experts. The conversation covers the critical step of cell collection & they also discuss the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and market. https://ow.ly/jgs350Skq7L
Biopharma 4.0 - Spearheading Digital Transformation in the Biopharmaceutical Industry
-
Senior Talent Acquisition Specialist @ Catalent Pharma Solutions | Recruiting, Employer Branding & Candidate Experience
In this episode of “The Top Line”, Fierce Pharma interviews Delara Motlagh, head of cell therapy at Catalent and other industry experts. The conversation covers the critical step of cell collection & they also discuss the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and market. https://ow.ly/jgs350Skq7L
From cell collection to commercial contracting: Advancements in cell & gene therapy manufacturing (Part II)
-
In this episode of “The Top Line”, Fierce Pharma interviews Delara Motlagh, head of cell therapy at Catalent and other industry experts. The conversation covers the critical step of cell collection & they also discuss the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and market. https://ow.ly/jgs350Skq7L
From cell collection to commercial contracting: Advancements in cell & gene therapy manufacturing (Part II)
-
In this episode of “The Top Line”, Fierce Pharma interviews Delara Motlagh, head of cell therapy at Catalent and other industry experts. The conversation covers the critical step of cell collection & they also discuss the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and market. https://ow.ly/jgs350Skq7L
From cell collection to commercial contracting: Advancements in cell & gene therapy manufacturing (Part II)
-
In this episode of “The Top Line”, Fierce Pharma interviews Delara Motlagh, head of cell therapy at Catalent and other industry experts. The conversation covers the critical step of cell collection & they also discuss the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and market. https://ow.ly/JfhN50Sz5n5
-
-
In this episode of “The Top Line”, Fierce Pharma interviews Delara Motlagh, head of cell therapy at Catalent and other industry experts. The conversation covers the critical step of cell collection & they also discuss the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and market. https://ow.ly/jgs350Skq7L
From cell collection to commercial contracting: Advancements in cell & gene therapy manufacturing (Part II)
-
In this episode of “The Top Line”, Fierce Pharma interviews Delara Motlagh, head of cell therapy at Catalent and other industry experts. The conversation covers the critical step of cell collection & they also discuss the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and market. https://ow.ly/jgs350Skq7L
From cell collection to commercial contracting: Advancements in cell & gene therapy manufacturing (Part II)
